Skip to main content
Molecular Pharmacology logoLink to Molecular Pharmacology
. 2021 Aug;100(2):65. doi: 10.1124/mol.109.061259retraction

Notice of Retraction: Acharya P, Chen J-J, Correia MA (2010) Hepatic heme-regulated inhibitor (HRI) eukaryotic initiation factor 2α kinase: a protagonist of heme-mediated translational control of CYP2B enzymes and a modulator of basal endoplasmic reticulum stress tone. Mol Pharmacol 77(4):575–592; doi:10.1124/mol.109.061259.

PMCID: PMC8382259  PMID: 34404736

At the request of the corresponding author and investigator at the University of California, San Francisco, and in consultation with Molecular Pharmacology, this paper has been retracted. It was found there was improper manipulation, reuse, and analyses represented by Figs. 1A, 1B, 1D, 2C, 3A, 3B, 4A, 5C, 6B, 6C, 8B, 9B, 9C, and 9D.

Footnotes


Articles from Molecular Pharmacology are provided here courtesy of American Society for Pharmacology and Experimental Therapeutics

RESOURCES